Brief: Mink Therapeutics Inc Reports Q1 Loss Per Share Of $0.17

Mink Therapeutics

11/05/2023 13:53

May 11 (Reuters) - Mink Therapeutics Inc  INKT.O :
    * MINK THERAPEUTICS REPORTS CORPORATE UPDATE AND FIRST
QUARTER
2023 FINANCIAL RESULTS
    * Q1 LOSS PER SHARE $0.17
    * ENDED Q1 2023 WITH A CASH BALANCE OF $14.9 MILLION
    * Q1 EARNINGS PER SHARE VIEW $-0.24 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX6rJvdN 
Further company coverage:  INKT.O 

 ((Reuters.Briefs@thomsonreuters.com;;))